Article
Melarsoprol Resistance in African Trypanosomiasis.
Trends in parasitology - 1 Jun 2018
Fairlamb Alan H, Horn David
Abstract excerpt
Arsenicals were introduced as monotherapies for the treatment of human African trypanosomiasis, or sleeping sickness, over 100 years ago. Toxicity has always been an issue but these drugs have proven to be both effective and quite durable. Unfortunately, melarsoprol-resistant parasites emerged as early as the 1970s and were widespread by the late 1990s. Resistance was due to mutations affecting an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
